Direct action of gliclazide on skeletal muscle carbohydrate metabolism

Diabetes, Nutrition and Metabolism - Clinical and Experimental

Volumn 9, Issue 3, 1996, Pages 115-121

  Webster, J M ^a   Taylor, R ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

Glycogen synthesis; Insulin action; Non insulin dependent diabetes; Skeletal muscle; Sulphonylurea therapy

Indexed keywords

GLICLAZIDE; GLYCOGEN; SULFONYLUREA DERIVATIVE;

ADULT; AGED; ANIMAL TISSUE; ARTICLE; CARBOHYDRATE METABOLISM; CONCENTRATION RESPONSE; CONTROLLED STUDY; GLYCOGEN SYNTHESIS; HUMAN; HUMAN TISSUE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RECTUS ABDOMINIS MUSCLE; SKELETAL MUSCLE; SOLEUS MUSCLE; TIME;

EID: 0029947901     PISSN: 03943402     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. + channel in insulin secreting ceils. J. Biol. Chem. 262: 15840-15844, 1987.
2. Vignen R., Pezzino V., Wong K.Y., Goldfine I.D.: Comparison of the in vitro effect of biguanides and sulphonylureas on insulin binding to its receptors in target cells. J. Clin. Endocrinol. Metab. 54: 95-100, 1982.
3. Keller U., Berger W.: Sulphonylurea therapy fails to diminish insulin resistance in type I diabetic subjects. Harm. Metab. Res. 18: 599-603, 1986.
4. Hosker J.P., Rudenski A.S., Burnett M.A., Matthews D.R., Turner R.C.: Similar reduction of first- and second-phase β-cell responses at three different glucose levels in type II diabetes and the effect of gliclazide therapy. Metabolism 38: 767-772, 1989.
5. Johnson A.B., Argyraki M., Thow J.C., Jones I.R., Broughton D., Miller M., Taylor R.: The effect of sulphonylurea therapy on skeletal muscle glycogen synthase activity and insulin secretion in newly presenting type 2 (noninsulin-dependent) diabetic patients. Diabetic Med. 8: 243-253, 1991.
6. Defronzo R.A., Jacot E., Jequier E., Maeder E., Wahren J., Felber J.P.: The effect of insulin on the disposal of intravenous glucose. Results from indirect calorimetry and hepatic and femoral venous catheterization. Diabetes 30: 1000-1007, 1981.
7. 13C nuclear magnetic resonance spectroscopy. N. Engl. J. Med. 322: 223-228, 1990.
8. Ferrannini E., Bjorkman O., Reichard G.A., Pilo A., Olsson M., Wahren J.: The disposal of an oral glucose load in healthy subjects. Diabetes 34: 580-588, 1985.
9. Thiebaud D.E., Jacot E., Defronzo R.A., Maeder E., Jequier E., Felber J.P.: The effect of graded doses of insulin on total glucose uptake, glucose oxidation and glucose storage in man. Diabetes 31: 957-963, 1982.
10. Crettaz M., Prentki M., Zaninetti D., Jeanrenaud B.: Insulin resistance in soleus muscle from obese Zucker rats. Biochem. J. 186: 525-534, 1980.
11. Stace P.E., Marchington D.R., Kerbey A.L., Randle P.J.: Long term culture of rat soleus muscle in vitro. Its effects on glucose utilization and insulin sensitivity. FEBS Lett. 273: 91-94, 1990.
12. Argyraki M., Wright P.D., Venables C.W., Proud G., Taylor R.: In vitro study of human skeletal muscle strips: Effect of nonesterified fatty acid supply on glucose storage. Metabolism 38: 1183-1187, 1989.
13. Cuendet G.S., Loten E.G., Jeanrenaud B., Renold A.E.: Decreased basal, noninsulin-stimulated glucose uptake and metabolism by skeletal soleus muscle isolated from obesehyperglycemic (ob/ob) mice. J. Clin. Invest. 58: 1078-1088, 1976.
14. Spielman H., Jacob-Muller U., Schulz P.: Simple assay of 0.1-1.0 pmol of ATP. ADP and AMP in single somatic cells using purified luciferin luciferase. Anal. Biochem. 113: 172-178, 1981.
15. Defronzo R.A., Gunnarsson R., Bjorkman O., Olsson M., Wahren J.: Effects of insulin on peripheral and splanchnic glucose metabolism in noninsulin dependent (type II) diabetes mellitus. J. Clin. Invest. 76: 149-155, 1985.
16. Damsbo P., Vaag A., Hother-Nielsen O., Beck-Nielsen H.: Reduced glycogen synthase activity in skeletal muscle from obese patients with and without type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 34: 239-245, 1991.
17. Johnson A.B., Argyraki M., Thow J.C., Jones I.R., Broughton D., Miller M., Taylor R.: Impaired activation of skeletal muscle glycogen synthase in non-insulin-dependant diabetes mellitus is unrelated to the degree of obesity. Metabolism 40: 252-260, 1991.
18. Kolterman O.G., Gray R.S., Griffin J., Burstein P., Insel J.: Receptor and postreceptor defects contribute to the insulin resistance in noninsulin dependent diabetes mellitus. J. Clin. Invest. 68: 957-969, 1981.
19. Caro J.F., Sinha M.K., Raju S.M., Ittoop O., Pories W.J., Flickinger E.G., Meelheim D., Dohm G.L.: Insulin receptor kinase in human skeletal muscle from obese subjects with and without noninsulin dependent diabetes. J. Clin. Invest. 79: 1330-1337, 1987.
20. Golay A., Defronzo R.A., Ferrannini E., Simonson D.C., Thorin D., Acheson K., Thiebaud D., Curchod B., Jequier E., Felber J.P.: Oxidative and non-oxidative glucose metabolism in non-obese type 2 (non-insulin-dependent) diabetic patients. Diabetologia 31: 585-591, 1988.
21. Meyer H.U., Curchod B., Maeder P., Pahud E., Jequier E., Felber J.P.: Modification of glucose storage and oxidation in nonobese diabetics, measured by continuous indirect calorimetry. Diabetes 29: 752-756, 1980.
22. Della Casa L., Del Rio G., Glaser B., Cerasi E.: Effect of 6-month gliclazide treatment on insulin release and sensitivity to endogenous insulin in Type 2 diabetic patients: Role of initial continuous subcutaneous insulin infusion-induced normoglycemia. Am. J. Med. 90: 37S-45S, 1991.
23. Johnson M.A., Polgar J., Weightman D., Appleton D.: Data and distribution of fibre types in 36 human muscles. An autopsy study. J. Neurol. Sci. 18: 111-129, 1973.
24. James D.E., Kraegen E.W., Chisholm D.J.: Muscle glucose metabolism in exercising rats: comparison with insulin stimulation. Am. J. Physiol 248: E575-E580, 1985.
25. Hanson R.W.: Is there a single best species for studies of metabolic regulation? Trends Biochem. Sci. 5 (6): I-II, 1980.
26. Feldman J.M., Lebovitz H.E., Durham N.C.: An insulin dependent effect of chronic tolbutamide administration on the skeletal muscle carbohydrate transport system. Diabetes 18: 84-94, 1969.
27. Bloch K., Daturi S., Tommasini R.: Effect of glipizide on muscle metabolism in vitro. Acta Endocrinol. Suppl. 239: 23-25, 1980.
28. Ma A., Kamp M., Bird D., Howlett V., Cameron D.P.: The effects of long term gliciazide administration on insulin secretion and insulin sensitivity. Aust. N. Z. J. Med. 19: 44-49, 1989.
29. Ward G., Harrison L.C., Proietto J., Aitken P., Nankervis A.: Gliclazide therapy is associated with potentiation of postbinding insulin action in obese, non-insulin-dependent diabetic subjects. Diabetes 34: 241-245, 1985.
30. Guinovart J.J., Salavert A., Massague J., Ciudad C.J., Salsas E., Itarte E.: Glycogen synthase: a new activity ratio assay expressing a high sensitivity to the phosphorylation state. FEBS Len. 106: 284-288, 1979.
31. Bak J.F., Schmitz O., Sorensen N.S., Pedersen O.: Postreceptor effects of sulphonylurea on skeletal muscle glycogen synthase activity in type n diabetic patients. Diabetes 38: 1343-1350, 1989.